Gainesville, FL, United States of America

Alexander V Glushakov

This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2003.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexander V Glushakov: Innovator in Neurological Treatment

Introduction

Alexander V Glushakov is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of neurological disorders through his innovative research and patents. His work focuses on the modulation of glutamate receptor activity, which plays a crucial role in treating various neurological conditions.

Latest Patents

One of his notable patents is titled "Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors." This invention pertains to methods for treating neurological conditions that can be affected by the modulation of glutamate receptor (GluR) activity. The treatment can be either prophylactic or aimed at alleviating symptoms of conditions such as ischemia, stroke, spinal cord injury, and traumatic brain injury. He holds 1 patent in this area.

Career Highlights

Alexander V Glushakov is associated with the University of Florida Research Foundation Inc., where he continues to advance his research in neurological treatments. His work has garnered attention for its potential to improve the quality of life for individuals suffering from debilitating neurological disorders.

Collaborations

He has collaborated with notable colleagues such as Anatoly E Martynyuk and Colin Sumners, contributing to a rich environment of research and innovation.

Conclusion

Alexander V Glushakov's contributions to the field of neurological treatment through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of various neurological disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…